tacrolimus ointment
teva pharmaceuticals usa, inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed warning , warnings and precautions: pediatric use ). tacrolimus ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.
ach-tacrolimus capsule (immediate release)
accord healthcare inc - tacrolimus - capsule (immediate release) - 0.5mg - tacrolimus 0.5mg - immunosuppressive agents
ach-tacrolimus capsule (immediate release)
accord healthcare inc - tacrolimus (tacrolimus monohydrate) - capsule (immediate release) - 1mg - tacrolimus (tacrolimus monohydrate) 1mg - immunosuppressive agents
ach-tacrolimus capsule (immediate release)
accord healthcare inc - tacrolimus (tacrolimus monohydrate) - capsule (immediate release) - 5mg - tacrolimus (tacrolimus monohydrate) 5mg - immunosuppressive agents
tacrolimus sandoz
sandoz new zealand limited - tacrolimus monohydrate 0.511mg equivalent to 0.5 mg tacrolimus - capsule - 0.5 mg - active: tacrolimus monohydrate 0.511mg equivalent to 0.5 mg tacrolimus excipient: capsugel ivory g4ics000511 croscarmellose sodium hypromellose lactose monohydrate magnesium stearate - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidneys) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.
tacrolimus sandoz
sandoz new zealand limited - tacrolimus monohydrate 1.022mg equivalent to 1 mg tacrolimus - capsule - 1 mg - active: tacrolimus monohydrate 1.022mg equivalent to 1 mg tacrolimus excipient: croscarmellose sodium hypromellose capsugel white/brown g4ics000510 lactose monohydrate magnesium stearate - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidneys) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.
tacrolimus sandoz
sandoz new zealand limited - tacrolimus monohydrate 5.11mg equivalent to 5 mg tacrolimus - capsule - 5 mg - active: tacrolimus monohydrate 5.11mg equivalent to 5 mg tacrolimus excipient: croscarmellose sodium hypromellose lactose monohydrate magnesium stearate opaque orange g3ics000767 - primary immunosuppression in liver, kidney, pancreas, kidney-pancreas, lung or heart allograft recipients and rescue use in liver, kidney or other solid organ (heart, lung, pancreas or kidneys) transplantation, that has either failed conventional immunosuppressive agents, or where such agents are producing intolerable side effects.
tacrolimus 0.5mg capsules hard
accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus - immunosuppressants
tacrolimus 1mg capsules hard
accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus 1 mg - immunosuppressants
tacrolimus 5mg hard capsules
accord healthcare limited sage house, 319, pinner road, north harrow, middlesex ha1 4hf, united kingdom - tacrolimus - hard capsule - tacrolimus 5 mg - immunosuppressants